Home Newsfeeds Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

Synchrony Financial Q2 Highlights: EPS Beats Consensus, Revenue In-Line, 2023 Outlook Revised

By Lekha Gupta

July 18, 7:32 AM

Synchrony Financial (NYSE: SYF) reported Q2 sales of $4.12 billion,

SYF

News

Garmin To Provide Motorcycle Infotainment Solutions To Yamaha Motor; Automotive OEM Connected Technology And Navigation Systems Will Power Next-gen Motorcycles And Smart Scooters

By Benzinga Newsdesk

January 8, 10:44 AM

Automotive OEM connected technology and navigation systems will power next-gen motorcycles and smart scootersOLATHE, Kan., Jan. 8, 2024 /PRNewswire/ -- Garmin (NYSE:GRMN) today announced it will provide state-of-the-art

GRMN

Bitcoin Falls Below $42,000; Sui, Helium Among Top Losers

By Avi Kapoor

January 19, 10:34 AM

Bitcoin (CRYPTO: BTC) moved lower, with the cryptocurrency prices falling below the key $42,000 level on Friday. Ethereum (CRYPTO: ETH) also recorded losses, trading below the key $2,500 mark this morning.

$AKT